As the molecular mechanism of Aza-mediated antitumor activity remains incompletely defined [51], our data suggest that KLF4 upregulation represents an important mechanism by which Aza eliminates B-ALL cells. The gene discussed is KLF4; the disease is acute lymphoblastic leukemia.